UCB is a global biopharma focused on severe diseases in two therapeutic areas: central nervous system and immunology operations.
The company is listed on the Euronext Brussels Stock Exchange and has its headquarters in Brussels, Belgium. It employs more than 8,500 people in more than 40 countries.
Financial Data
-
31st Dec 18 Source: CRO
- €36.9 million turnover
-
€25.8 million
profit - 1 employees
-
31st Dec 17 Source: CRO
- €163 million turnover
-
€12.2 million
profit - 1 employees
- 10 more years available »
Ranking
By Turnover
(€36.9 million)- 755th in Top Companies
- 88th in Health
- 75th in Pharma
By Employees
(1)- 986th in Top Companies
- 94th in Health
- 81st in Pharma
-
- 1
- €36.9 million
Employees
- Steve Turley CEO/Managing Director
Latest News
- 10:50am Workvivo to create 100 new jobs in Cork as business booms
- 10:35am PTSB names Grant Thornton partner as interim CFO
- 10:18am Revenue pays out over €12.1m in ‘sweepback payments’ under EWSS
- 9:43am Korn Ferry Ireland appoints Bob Casey managing director
- 8:59am Tourism jobs slump 25% as Covid-19 wreaks havoc on sector